Symbiotic Capital Management Co LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Symbiotic Capital Management Co LLC
CRD #325844
SEC #801-128442
CIK #
AUM 1,134.5 M (2026-03-31)
Employees 9 (67% Investors, 0% Brokers)
Fees
Minimum
Phone424-313-1550
Address10100 Santa Monica Blvd
Los Angeles, CA 90067
Source [IAPD] [Website] [LinkedIn]
Total AUM ($M)
120096072048024002010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
ITEM 5 - FEES AND COMPENSATION
Investors should consult the Funds Governing Documents for more details regarding the calculation
of fees and expenses.

Management Fee

The Adviser will receive an annual management fee (the “Management Fee”) with respect to each
Limited Partner equal to 1.75% per annum multiplied by the sum of (i) such Limited Partner’s
capital contributions relating to all portfolio investments that have not been the subject of a
disposition or write off, together with expenses related thereto, (ii) any outstanding and binding
commitments by the Fund, in each case calculated as an average of the first day and the last day of
such quarter and (iii) the non-cash proceeds of any portfolio investment if and to the extent the same

do not constitute proceeds from a disposition. Any indebtedness incurred in lieu of a capital
contribution will be treated as a capital contribution for purposes of calculating the Management
Fee. For purposes of clauses (i) and (ii), capital contributions related to portfolio investments and
binding commitments to make portfolio investments shall, in each case, be deemed to have been
outstanding for a 90-day period prior to the closing of such investment.

The Management Fee is subject to reduction as provided below in “Organizational Expenses” and
“Fee Income.”

The Management Fee is payable quarterly in arrears from drawdowns of the Limited Partners’
unfunded Commitments (or use of the subscription line) or other proceeds received by the Fund.

Performance-Based Compensation

As described in further detail in the Funds Governing Documents, the General Partner will receive
performance-based compensation in the form of an incentive fee (“Carried Interest”) equal to
20%, with a threshold of 8%.

Co-Investments

The General Partner may, in its sole discretion, allocate co-investment opportunities to strategic and
other investors, lenders, and/or one or more Limited Partners. Co-investment opportunities may be
made available through limited partnerships or other entities formed to make such investments, with
or without payment of a carried interest or management fee (a “Co-Investment Fund”). The General
Partner will allocate available investment opportunities among the Fund, any Co-Investment Fund,
and any third parties as it may in its sole discretion determine. The terms of co-investments may
differ from those of the Fund, including with respect to the payment of carried interest and
management fees.

At its discretion, the General Partner may also structure any co-investment opportunity such that
participants in such co-investment opportunity do not bear any broken deal expenses, resulting in
the Fund bearing all such broken deal expenses.

Organizational and Operating Expenses

The Funds will bear all legal and other expenses incurred in the formation of the Funds and the
offering of the Interests (other than any placement fees), up to an amount not to exceed amounts
described in the LPA. Organizational expenses in excess of this amount, and any placement fees,
will be borne by the Adviser through a 100% offset against the Management Fee (if paid by the
Fund) or otherwise.

The Adviser will pay all normal operating expenses incidental to the provision of the day-to-day
administrative services to the Fund, including salaries for its employees and rent, utilities and other
ordinary and recurring expenses of management.

As further described in the Partnership Agreements, the Funds will pay all costs, expenses, and
liabilities in connection with its operations and activities (“Fund Expenses”), including: fees and
expenses related to consummated and unconsummated investments, including the evaluation,
acquisition, holding and disposition thereof; interest on and fees and expenses related to or arising
from indebtedness or hedging activities of the Funds; insurance premiums; taxes; fees and expenses
of accountants, counsel, and consultants; legal, custodial, administration, auditing, accounting and
regulatory and compliance expenses; costs of reporting to and meeting with the Partners and
governmental authorities; costs and expenses of the Advisory Committee and the annual meeting;
litigation expenses; and other extraordinary expenses.

Side Letters

The General Partner may enter into side letters or other agreements with individual Limited Partners
that have the effect of establishing rights under, or altering or supplementing, the terms of the
Partnership Agreement. Any rights established or any terms of the Partnership Agreement altered
or supplemented in a side letter with a Limited Partner will govern with respect to such Limited
Partner. In addition, the General Partner may permit certain Limited Partners, including those that
are affiliated with the General Partner (including for these purposes any executive partner, officer,
employee, service provider, advisor or team member of the Adviser or its affiliates and, in each
case, their respective family members, estate planning vehicles and family offices), to invest in the
Funds on a no fee or reduced fee and/or no Carried Interest or reduced Carried Interest basis.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
ITEM 7 - TYPES OF CLIENTS
The Adviser’s clients are the Funds. Currently, all Clients are Funds, structured as limited
partnerships formed in Delaware and operate pursuant to one or more exemptions from registration
under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

The Limited Partners in the Funds are expected to include taxable and tax-exempt entities and may
include institutions from non-US jurisdictions. The minimum capital commitment for a limited
partner of the Funds is $10 million, although the General Partner may accept capital commitments
of lesser amounts.
Type Form D Funds Date Sold AUM
Other SC Healthcare Credit Parallel Fund II A LP [2026-03-31] 100.0 M 117.5 M
Filed 2025-11-24 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $7,500,000 · Revenue Decline to Disclose
Other SC Opportunities Holding LP 2026-03-31 34.7 M
Other Symbiotic Capital Healthcare Credit Fund II LP [2026-03-31] 67.5 M 115.7 M
Filed 2025-11-24 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $7,500,000 · Revenue Decline to Disclose
Other Symbiotic Capital Healthcare Credit Parallel Fund II LP [2026-03-31] 137.9 M 155.0 M
Filed 2025-11-24 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $7,500,000 · Revenue Decline to Disclose
Other SC Life Science Credit Parallel Fund A LP [2025-03-31] 242.4 M 247.4 M
Filed 2025-05-23 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other Symbiotic Capital EB Fund LP [2025-03-31] 15.1 M
Filed 2025-03-11 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
Other Symbiotic Capital EB Parallel Fund LP [2025-03-31] 8.8 M
Filed 2025-03-11 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
Other Symbiotic Capital Life Science Credit Fund LP [2023-06-01] 160.2 M 172.5 M
Filed 2025-05-23 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Commission $1,200,000 · Net Assets Decline to Disclose
Other Symbiotic Capital Life Science Credit Parallel Fund LP [2023-06-01] 176.4 M 267.7 M
Filed 2025-05-23 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Commission $1,200,000 · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 1,134.5
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 9 1,134.5
By Discretionary
Discretionary 8 1,099.8
Non-Discretionary 1 34.7
Total 9 1,134.5
By Non-United States Persons
Non-United States Persons 370.8
United States Persons 763.7
Total 9 1,134.5
Form D Directors Role # Filings # Firms 2011 - 2026
Arie Belldegrun Director 50 6
Joshua Kazam Director 60 3
Daniel Kim Director 47 3
Joshua Bradley Director 32 3
Benjamin Belldegrun Director 7 3
Franz Humer Director 6 2
Russell Goldsmith Director 8 1
Himani Bhalla Director 8 1
Symbiotic Capital Life Science Credit Fund GP LP Promoter 5 1
Symbiotic Capital Healthcare Credit Fund II GP LP Promoter 3 1
View All
Firm Profile (Form ADV)
ServesInstitutional
Comparable Firms State AUM
Astatine Asset Management LLC
CT 1,150.1 M
Viking Fund Management LLC
ND 1,149.5 M
1WS Capital Advisors LLC
NY 1,142.6 M
Yosemite Management LLC
CA 1,135.7 M
HM International LLC
TX 1,134.4 M
iCapital Fund Advisors LLC
NY 1,132.6 M
Amundi US Investment Advisors LLC
MA 1,132.5 M
Moonrise Capital LP
FL 1,128.2 M
WITT Lake Asset Management LLC
CT 1,120.4 M
New Century Partners
1,118.9 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com